While our therapy groups establish a structure for developing and marketing our products, the whole company is unified by the key principles of addressing unmet medical needs, exploring innovative technologies and treatment approaches, and improving the lives of patients worldwide. By collaborating together, we can fulfill Genzyme’s mission to develop and deliver transformative therapies for patients.
We are committed to becoming a long-term partner to the Multiple Sclerosis community by working to deliver scientific advancements that will have a significant impact on the needs of people living with Multiple Sclerosis.
Focusing on uncommon and under-served medical conditions, our Rare Disease therapy group develops breakthrough therapies for patients who might otherwise have few treatment options.
Focusing on the treatment of thyroid cancer, our Endocrinology business sits within our Rare Disease therapy group.